100
Views
2
CrossRef citations to date
0
Altmetric
Hormone Therapy in Bone Marrow Carcinomatosis

Use of hormone therapies in disseminated carcinomatosis of the bone marrow associated with hormone receptor-positive breast cancer

, , , , , & show all
Pages 286-289 | Received 25 Apr 2017, Accepted 12 Oct 2017, Published online: 26 Oct 2017

References

  • Jarcho S. Diffusely infiltrative carcinoma. A hitherto undescribed correlation of several varieties of tumor metastasis. Arch Pathol 1936;22:674–96.
  • Hayashi H, Haruyama H, Emura Y, et al. Disseminated carcinomatosis of the bone marrow – study of a type of metastatic cancer and relationship of microangiopathic hemolytic anemia or disseminated intravascular coagulation. Jpn J Cancer Clin 1979;25:329–43.
  • Kopp HG, Krauss K, Fehm T, et al. Symptomatic bone marrow involvement in breast cancer-clinical presentation, treatment, and prognosis: a single institution review of 22 cases. Anticancer Res 2011;31:4025–30.
  • Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer 2011;11:411–25.
  • Braun S, Pantel K, Müller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525–33.
  • Iguchi H. Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: what has been done for the past, and what will be needed in future? WJG 2015;21:12249–60.
  • Rieker O, Grünwald F, Layer G, et al. Disseminated bone marrow metastases from primary breast cancer: detection and follow-up by radioimmune bone marrow scintigraphy. J Nucl Med 1994;35:1485–7.
  • Kanno M, Nakamura S, Uotani C, et al. Prognosis of node-positive breast cancer patients who underwent parasternal lymph node biopsy during surgery followed by doxorubicin- or mitoxantrone-containing adjuvant chemotherapy. J Chemother 2000;12:435–41.
  • Maruta K, Wakimoto J, Sonoda Y, et al. Autopsy case of dural thickening caused by widespread dural vein thrombosis associated with disseminated bone marrow carcinomatosis. Rinsho Shinkeigaku 2010;50:232–40.
  • Ishikawa T, Shimizu D, Kito A, et al. Breast cancer manifested by hematologic disorders. J Thorac Dis 2012;4:650–4.
  • Takayama S, Ueno H, Kawaguchi S, et al. A case of bone marrow carcinomatosis from breast cancer treated with weekly paclitaxel. Gan to Kagaku Ryoho 2012;39:99–101.
  • Kawai H, Sugimoto R, Miyauchi S, et al. A case of bone marrow carcinomatosis with disseminated intravascular coagulation arising from breast cancer successfully treated with paclitaxel plus bevacizumab. Gan to Kagaku Ryoho 2014;41:1957–9.
  • Kamata A, Hagiwara H, Koizumi M, et al. A case of disseminated bone marrow carcinomatosis arising from breast cancer for which paclitaxel and bevacizumab treatment was effective. Gan to Kagaku Ryoho 2016;43:103–6.
  • Kusumoto H, Haraguchi M, Nozuka Y, et al. Characteristic features of disseminated carcinomatosis of the bone marrow due to gastric cancer: the pathogenesis of bone destruction. Oncol Rep 2006;16:735–40.
  • Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004;350:1655–64.
  • Levi M. Management of cancer-associated disseminated intravascular coagulation. Thromb Res 2016;140 Suppl 1:S66–S70.
  • Nayak L, Abrey LE, Iwamoto FM. Intracranial dural metastases. Cancer 2009;115:1947–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.